Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
82.1M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
229K
-
Shares change
-
+229K
-
Total reported value, excl. options
-
$3.77M
-
Value change
-
+$3.77M
-
Number of buys
-
2
-
Price
-
$16.46
Significant Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) as of Q4 2020
2 filings reported holding VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value as of Q4 2020.
Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 229K shares
of 82.1M outstanding shares and own 0.28% of the company stock.
Largest 2 shareholders include Atlas Venture Advisors, Inc. (210K shares) and VR Adviser, LLC (19.5K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.